Formulation evaluation and stability studies of hydrogel tablets containing Cefditoren Pivoxil

Hoffman, 1998, Pharmacodynamic aspects of sustained release preparation, Adv Drug Deliv Rev, 33, 185, 10.1016/S0169-409X(98)00027-1 Kennth, 2007, Critical review of gastric retentive controlled drug delivery, Pharm Dev Technol, 12, 1, 10.1080/10837450601168680 Chen, 2000, Gastric retention properties of super porous hydrogel composites, J Control Release, 64, 39, 10.1016/S0168-3659(99)00139-X Peppas, 2000, Hydrogels in pharmaceutical formulations, Eur J Pharm Biopharm, 50, 27, 10.1016/S0939-6411(00)00090-4 2005, vol. 7, 2824 Yamada, 2007, Crystal structure of cefditoren complexed with Streptococcus pneumonia penicillin-binding protein 2X: structural basis for its high antimicrobial activity, Antimicrobial Agents Chemother, 51, 3902, 10.1128/AAC.00743-07 Alvarez Sala, 2006, Clinical and bacteriological efficacy in treatment of acute exacerbations of chronic bronchitis with cefditoren pivoxil versus cefuroxime axetil, Antimicrobial Agents Chemother, 50, 1762, 10.1128/AAC.50.5.1762-1767.2006 Liu, 2008, Zero-order delivery of a highly soluble low dose drug lfuzosin hydrochloride via gastro-retentive system, Int J Pharm, 348, 27, 10.1016/j.ijpharm.2007.07.009 Punna, 2007, Design and study of lamivudine oral controlled release tablets, AAPS PharmSci Tech, 8, 1 Khan, 2007, Taste masking of ondansetron hydrochloride by polymer carrier system and formulation of rapid-disintegrating tablets, AAPS PharmSci Tech, 8, 1, 10.1208/pt0802046 Allen, 2005, Ansel’s pharmaceutical dosage forms and drug delivery system, 227 Di Colo, 2006, A new hydrogel for the extended and complete prednisolone release in the GI tract, Int J Pharm, 310, 154, 10.1016/j.ijpharm.2005.12.002 Hashmat, 2008, Development of enteric coated flurbiprofen tablets using opadry/acryl-eze system—a technical note, AAPS Pharm Sci Tech, 9, 116, 10.1208/s12249-007-9005-9